Uterine Sarcoma Treatment Market To Reach USD 5.9 Billion By 2032 | DataHorizzon Research
May 14, 2024 01:52 ET
|
DataHorizzon Research
Fort Collins, Colorado, May 14, 2024 (GLOBE NEWSWIRE) -- Rising incidences of uterine sarcoma in the population drive the need for treatment. The growth of the uterine sarcoma treatment market is...
Nykode Therapeutics Announces Clinical Collaboration with MSD to Evaluate VB10.16 in Combination with KEYTRUDA® (pembrolizumab) in Patients with HPV16-Positive High-Risk Locally Advanced Cervical Cancer
May 14, 2024 01:15 ET
|
Nykode Therapeutics ASA
OSLO, Norway, May 14, 2024 (GLOBE NEWSWIRE) -- Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies,...
Consumer Stationery Retailing Market To Reach USD 87.5 Billion By 2032 | DataHorizzon Research
May 14, 2024 00:58 ET
|
DataHorizzon Research
Fort Collins, Colorado, May 14, 2024 (GLOBE NEWSWIRE) -- The rise in investments in educational activities has encouraged market growth. The consumer stationery retailing market is experiencing...
Dual Cure Adhesives Market To Reach USD 440.2 Million By 2032, Says DataHorizzon Research
May 14, 2024 00:50 ET
|
DataHorizzon Research
Fort Collins, Colorado, May 14, 2024 (GLOBE NEWSWIRE) -- Huge demand from the automotive industry drives the industry demand. The automotive industry is a significant driving force behind...
MKS Instruments Announces Pricing of Upsized Private Offering of $1.2 Billion of 1.25% Convertible Senior Notes
May 13, 2024 23:01 ET
|
MKS Instruments, Inc.
ANDOVER, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI) (“MKS”) today announced the pricing of its offering of $1.2 billion aggregate principal amount of 1.25%...
Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
May 13, 2024 21:50 ET
|
Belite Bio, Inc
Tinlarebant is Belite Bio’s orally administered tablet intended to slow disease progression in patients affected with Stargardt Disease (STGD1) and Geographic Atrophy (GA) in advanced Dry Age-related...
GLOBAL LIFE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Global Life, Inc. and Encourages Investors to Contact the Firm
May 13, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...
High Arctic to Announce 2024 First Quarter Results
May 13, 2024 20:50 ET
|
High Arctic Energy Services Inc.
High Arctic 2024 First Quarter Conference Call Details
AKRO INVESTOR ALERT: Edelson Lechtzin LLP Urges Akero Therapeutics, Inc. (NASDAQ: AKRO) Shareholders to Seek Legal Counsel About the Pending Securities Fraud Class Action
May 13, 2024 20:29 ET
|
Edelson Lechtzin LLP
Edelson Lechtzin LLP is investigating securities fraud claims on behalf of investors in Akero Therapeutics, Inc. (NASDAQ: AKRO)
Pacific Health Care Organization, Inc. Reports its First Quarter 2024 Results
May 13, 2024 20:22 ET
|
Pacific Health Care Organization, Inc.
Irvine, May 13, 2024 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed with the Securities and Exchange Commission (the “Commission”) its...